Literature DB >> 35993010

Increased risk of cancer in dogs and humans: a consequence of recent extension of lifespan beyond evolutionarily-determined limitations?

Aaron L Sarver1,2,3, Kelly M Makielski1,3,4, Taylor A DePauw1,3,4, Ashley J Schulte1,3,4, Jaime F Modiano1,3,4,5,6,7,8.   

Abstract

Cancer is among the most common causes of death for dogs (and cats) and humans in the developed world, even though it is uncommon in wildlife and other domestic animals. We provide a rationale for this observation based on recent advances in our understanding of the evolutionary basis of cancer. Over the course of evolutionary time, species have acquired and fine-tuned adaptive cancer protective mechanisms that are intrinsically related to their energy demands, reproductive strategies, and expected lifespan. These cancer protective mechanisms are general across species and/or specific to each species and their niche, and they do not seem to be limited in diversity. The evolutionarily acquired cancer-free longevity that defines a species' life history can explain why the relative cancer risk, rate, and incidence are largely similar across most species in the animal kingdom despite differences in body size and life expectancy. The molecular, cellular, and metabolic events that promote malignant transformation and cancerous growth can overcome these adaptive, species-specific protective mechanisms in a small proportion of individuals, while independently, some individuals in the population might achieve exceptional longevity. In dogs and humans, recent dramatic alterations in healthcare and social structures have allowed increasing numbers of individuals in both species to far exceed their species-adapted longevities (by 2-4 times) without allowing the time necessary for compensatory natural selection. In other words, the cancer protective mechanisms that restrain risk at comparable levels to other species for their adapted lifespan are incapable of providing cancer protection over this recent, drastic and widespread increase in longevity.

Entities:  

Keywords:  cancer protective mechanisms; cancer risk; evolution; longevity

Year:  2022        PMID: 35993010      PMCID: PMC9387675          DOI: 10.1002/aac2.12046

Source DB:  PubMed          Journal:  Aging Cancer        ISSN: 2643-8909


  162 in total

1.  Connecting Cancer to Its Causes Requires Incorporation of Effects on Tissue Microenvironments.

Authors:  James DeGregori
Journal:  Cancer Res       Date:  2017-07-28       Impact factor: 12.701

Review 2.  Infection and cancer in multicellular organisms.

Authors:  Paul W Ewald; Holly A Swain Ewald
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-07-19       Impact factor: 6.237

3.  Height at diagnosis and birth-weight as risk factors for osteosarcoma.

Authors:  Lisa Mirabello; Ruth Pfeiffer; Gwen Murphy; Najat C Daw; Ana Patiño-Garcia; Rebecca J Troisi; Robert N Hoover; Chester Douglass; Joachim Schüz; Alan W Craft; Sharon A Savage
Journal:  Cancer Causes Control       Date:  2011-04-05       Impact factor: 2.506

4.  Oral squamous cell carcinoma in a coyote (Canis latrans).

Authors:  K S Bernstein; S H Schelling
Journal:  J Zoo Wildl Med       Date:  1999-06       Impact factor: 0.776

5.  Lifetime cancer prevalence and life history traits in mammals.

Authors:  Amy M Boddy; Lisa M Abegglen; Allan P Pessier; Athena Aktipis; Joshua D Schiffman; Carlo C Maley; Carmel Witte
Journal:  Evol Med Public Health       Date:  2020-05-25

6.  Phylostratigraphic tracking of cancer genes suggests a link to the emergence of multicellularity in metazoa.

Authors:  Tomislav Domazet-Loso; Diethard Tautz
Journal:  BMC Biol       Date:  2010-05-21       Impact factor: 7.431

Review 7.  Review of 2,4-dichlorophenoxyacetic acid (2,4-D) epidemiology and toxicology.

Authors:  David H Garabrant; Martin A Philbert
Journal:  Crit Rev Toxicol       Date:  2002-07       Impact factor: 5.635

8.  Multi-omics approach identifies germline regulatory variants associated with hematopoietic malignancies in retriever dog breeds.

Authors:  Jacquelyn M Evans; Heidi G Parker; Gerard R Rutteman; Jocelyn Plassais; Guy C M Grinwis; Alexander C Harris; Susan E Lana; Elaine A Ostrander
Journal:  PLoS Genet       Date:  2021-05-13       Impact factor: 5.917

9.  Porcine cancer models for translational oncology.

Authors:  Jessica C Sieren; Dawn Quelle; David K Meyerholz; Christopher S Rogers
Journal:  Mol Cell Oncol       Date:  2014-11-11

10.  Increased somatic mutation burdens in normal human cells due to defective DNA polymerases.

Authors:  Philip S Robinson; Tim H H Coorens; Claire Palles; Emily Mitchell; Federico Abascal; Sigurgeir Olafsson; Bernard C H Lee; Andrew R J Lawson; Henry Lee-Six; Luiza Moore; Mathijs A Sanders; James Hewinson; Lynn Martin; Claudia M A Pinna; Sara Galavotti; Raheleh Rahbari; Peter J Campbell; Iñigo Martincorena; Ian Tomlinson; Michael R Stratton
Journal:  Nat Genet       Date:  2021-09-30       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.